http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-8047-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eb9667071f40bd09df47436437f0651
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90de6bf2df64c2ad4970963062f97416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc4b2cae4f43c8f38cbd33a1ae2462f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca14bc0cc6cba31850418baa3bbeaef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c88df3ae156bf4fb18a526e6476afe
publicationDate 2006-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-8047-A
titleOfInvention TREATMENT PROCEDURE OF ARTEROSCLEROSIS, DYSLIPIDEMIES AND RELATED AFFECTIONS AND PHARMACEUTICAL COMPOSITIONS
abstract A procedure for treating atherosclerosis is described, in which the patient is administered nicotinic acid or another nicotinic acid receptor agonist in combination with another DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate blushing, which might otherwise occur.
priorityDate 2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID338442
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8TDS4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80885
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ80Z39
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557067
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID353250
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID527744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9EP66

Total number of triples: 42.